Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Baer

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Cancer|June 1, 1986
Malignant histiocytoses developing in patients with B-cell lymphomas. Report of two casesM R Baer, S B Krantz, J B Cousar, et al.
Leukemia|November 1, 1990
Trisomy/tetrasomy 13 in seven cases of acute leukemiaC Sreekantaiah, M R Baer, S Morgan, et al.
Leukemia Research|September 21, 2007
Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)P W Wijermans, B Rüter, M R Baer, et al.
Southern Medical Journal|July 1, 1986
Clinical experience with amphotericin B in acute myelogenous leukemiaR S Stein, J P Greer, W Ferrin, et al.
Blood|May 23, 1998
Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cellsR Sood, C C Stewart, P D Aplan, et al.
Cancer Research|March 14, 2001
A novel serine-dependent proteolytic activity is responsible for truncated signal transducer and activator of transcription proteins in acute myeloid leukemia blastsZ Xia, R R Salzler, D P Kunz, et al.
Leukemia|June 23, 2004
Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and functionA Suvannasankha, H Minderman, K L O'Loughlin, et al.
Annals of Hematology|May 6, 2004
P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adultsJ E Kolitz, S L George, M R Baer, et al.
Cancer Treatment Reports|June 1, 1986
Modified cyclophosphamide, vincristine, methotrexate, leucovorin, and cytarabine (COMLA) in intermediate- and high-grade lymphoma: an effective short-course regimenM R Baer, R S Stein, J P Greer, et al.
Oncogene|May 30, 2012
Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemiasL A Tobin, C Robert, A P Rapoport, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Cancer|June 1, 1986
Malignant histiocytoses developing in patients with B-cell lymphomas. Report of two casesM R Baer, S B Krantz, J B Cousar, et al.
Leukemia|November 1, 1990
Trisomy/tetrasomy 13 in seven cases of acute leukemiaC Sreekantaiah, M R Baer, S Morgan, et al.
Leukemia Research|September 21, 2007
Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)P W Wijermans, B Rüter, M R Baer, et al.
Southern Medical Journal|July 1, 1986
Clinical experience with amphotericin B in acute myelogenous leukemiaR S Stein, J P Greer, W Ferrin, et al.
Blood|May 23, 1998
Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cellsR Sood, C C Stewart, P D Aplan, et al.
Cancer Research|March 14, 2001
A novel serine-dependent proteolytic activity is responsible for truncated signal transducer and activator of transcription proteins in acute myeloid leukemia blastsZ Xia, R R Salzler, D P Kunz, et al.
Leukemia|June 23, 2004
Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and functionA Suvannasankha, H Minderman, K L O'Loughlin, et al.
Annals of Hematology|May 6, 2004
P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adultsJ E Kolitz, S L George, M R Baer, et al.
Cancer Treatment Reports|June 1, 1986
Modified cyclophosphamide, vincristine, methotrexate, leucovorin, and cytarabine (COMLA) in intermediate- and high-grade lymphoma: an effective short-course regimenM R Baer, R S Stein, J P Greer, et al.
Oncogene|May 30, 2012
Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemiasL A Tobin, C Robert, A P Rapoport, et al.
Pageof 10